Elissa Cote

Corporate Officer/Principal at VISTAGEN THERAPEUTICS, INC.

Net worth: - $ as of 2026-07-30

51 year

Health Technology

Consumer Services

Profile

Elissa S.
Cote is Chief Corporate Development Officer at Vistagen Therapeutics, Inc. since 2025.
Formerly, Ms. Cote was Vice President-Marketing & External Relations at Histogenics Corp.
Ms. Cote was Senior Vice President-Global Strategic Marketing at Sucampo Pharmaceuticals LLC from 2015 to 2018.
Ms. Cote completed undergraduate studies at Union College (New York).

Known holdings in public companies

Company	Date	Number of shares	Valuation	Valuation date
VISTAGEN THERAPEUTICS, INC. -.--%	2026-07-21	0 ( -.--% )	- $	2026-07-30

Elissa Cote active positions

Companies	Position	Start
VISTAGEN THERAPEUTICS, INC.	Corporate Officer/Principal	2025-06-22

All active positions of Elissa Cote

Former positions of Elissa Cote

Companies	Position	End
SUCAMPO PHARMACEUTICALS, INC.	Sales & Marketing	2018-01-31
OCUGEN, INC.	Sales & Marketing	-

See the detail of Elissa Cote's experience

Training of Elissa Cote

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Elissa Cote's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	4
Histogenics Corp. Histogenics Corp. BiotechnologyHealth Technology Develops and commercializes regenerative medicine	Health Technology
Union College (New York) Union College (New York) Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Sucampo Pharmaceuticals LLC Sucampo Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Manufactures prostone based pharmaceuticals products	Health Technology
VistaGen Therapeutics, Inc. VistaGen Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops central nervous system therapies	Health Technology